Rhumbline Advisers lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 65,329 shares of the medical equipment provider’s stock after selling 10,830 shares during the period. Rhumbline Advisers’ holdings in Intuitive Surgical were worth $61,107,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Guardian Life Insurance Co. of America raised its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the last quarter. D. Scott Neal Inc. acquired a new stake in shares of Intuitive Surgical during the second quarter valued at about $120,000. Parallel Advisors LLC raised its stake in shares of Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares during the last quarter. Huntington National Bank raised its stake in shares of Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of Intuitive Surgical during the first quarter valued at about $190,000. Institutional investors and hedge funds own 96.84% of the company’s stock.

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at 929.38 on Friday. The company’s 50 day moving average is $941.48 and its 200 day moving average is $831.70. Intuitive Surgical, Inc. has a one year low of $610.71 and a one year high of $974.66. The company has a market cap of $34.53 billion, a P/E ratio of 44.51 and a beta of 0.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, topping analysts’ consensus estimates of $5.79 by $0.16. The firm had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The company’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter last year, the business earned $5.62 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Intuitive Surgical, Inc. (ISRG) Shares Sold by Rhumbline Advisers” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/11/intuitive-surgical-inc-isrg-shares-sold-by-rhumbline-advisers.html.

Several equities research analysts have issued reports on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a research note on Monday, April 24th. Barclays PLC reiterated a “buy” rating and issued a $830.00 price target (up from $800.00) on shares of Intuitive Surgical in a research note on Wednesday, April 19th. Canaccord Genuity reiterated a “buy” rating and issued a $870.00 price target (up from $800.00) on shares of Intuitive Surgical in a research note on Wednesday, April 19th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $800.00 to $850.00 and gave the company a “buy” rating in a research note on Wednesday, April 19th. Finally, Citigroup Inc. reiterated a “buy” rating and issued a $917.00 price target (up from $820.00) on shares of Intuitive Surgical in a research note on Saturday, April 22nd. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $980.03.

In other Intuitive Surgical news, SVP Mark J. Meltzer sold 3,000 shares of the stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the completion of the transaction, the senior vice president now owns 3,046 shares in the company, valued at $2,702,076.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Jamie Samath sold 1,946 shares of the stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $921.26, for a total transaction of $1,792,771.96. Following the transaction, the vice president now owns 130 shares of the company’s stock, valued at approximately $119,763.80. The disclosure for this sale can be found here. Insiders have sold 34,065 shares of company stock valued at $31,659,090 in the last quarter. Company insiders own 2.50% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.